Gemini Therapeutics
(NASDAQ:GMTX)
$1.56
At close: Aug 5
$1.55
-0.0100[-0.64%]
PreMarket: 8:01AM EDT
Day High/Low- - -
52 Week High/Low1.16 - 3.1
Open / Close- / -
Float / Outstanding22.4M / 43.2M
Vol / Avg.- / 152.8K
Mkt Cap67.4M
P/E-
50d Avg. Price1.54
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float22.4M

Gemini Therapeutics (NASDAQ:GMTX), Quotes and News Summary

Gemini Therapeutics (NASDAQ: GMTX)

Day High/Low- - -
52 Week High/Low1.16 - 3.1
Open / Close- / -
Float / Outstanding22.4M / 43.2M
Vol / Avg.- / 152.8K
Mkt Cap67.4M
P/E-
50d Avg. Price1.54
Div / Yield-
Payout Ratio-
EPS-0.35
Total Float22.4M
Sector: Health Care.Industry: Biotechnology
Gemini Therapeutics Inc is a clinical-stage precision medicine company developing novel therapeutic compounds to treat genetically defined AMD. Its candidate, GEM103, is a recombinant form of the Complement Factor H protein (CFH) and is designed to address both complement hyperactivity and restore retinal health. Variations in the gene that encodes CFH strongly correlate with an increased risk of developing AMD.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-19
REV
Q1 2022Est.ActualSurprise
EPS-0.300-0.350 -0.0500
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Gemini Therapeutics Questions & Answers

Q
How do I buy Gemini Therapeutics (GMTX) stock?
A

You can purchase shares of Gemini Therapeutics (NASDAQ: GMTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Gemini Therapeutics's (GMTX) competitors?
Q
What is the target price for Gemini Therapeutics (GMTX) stock?
A

The latest price target for Gemini Therapeutics (NASDAQ: GMTX) was reported by HC Wainwright & Co. on Friday, March 11, 2022. The analyst firm set a price target for 2.00 expecting GMTX to rise to within 12 months (a possible 28.21% upside). 7 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Gemini Therapeutics (GMTX)?
A

The stock price for Gemini Therapeutics (NASDAQ: GMTX) is $1.56 last updated August 5, 2022, 8:00 PM UTC.

Q
Does Gemini Therapeutics (GMTX) pay a dividend?
A

There are no upcoming dividends for Gemini Therapeutics.

Q
When is Gemini Therapeutics (NASDAQ:GMTX) reporting earnings?
A

Gemini Therapeutics’s Q2 earnings are confirmed for Friday, August 19, 2022.

Q
Is Gemini Therapeutics (GMTX) going to split?
A

There is no upcoming split for Gemini Therapeutics.

Q
What sector and industry does Gemini Therapeutics (GMTX) operate in?
A

Gemini Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.